Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Recruiting 6Active not recruiting 4Unknown 1Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 68NETWORK 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Breast 1

Conditions

Renal Insufficiency, Chronic 1Prostate Cancer Metastatic 1Neoplasm Metastasis 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 18Cyclophosphamide 17Magnetic Resonance Spectroscopy 16Dexamethasone 15Cisplatin 14Vincristine 13Radiotherapy 13Radiation 11Etoposide 10Carboplatin 10durvalumab 9Radiotherapy, Intensity-Modulated 9Paclitaxel 9Doxorubicin 8Cytarabine 8Temozolomide 7Rituximab 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6tremelimumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Standard of Care × Clear all
NCT04467021 2026-05-06

Cancer and Blood Pressure Management, CARISMA Study

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
61 enrolled
Genitourinary

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT05568472 2026-04-02

ASPEN

SWOG Cancer Research Network

Phase NA Active not recruiting
565 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT03784755 2026-03-27

PLATON

Canadian Cancer Trials Group

Phase NA Active not recruiting
409 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡